Edgewise Therapeutics, Inc. Other
Cover page items of the 10-K and 10-Q that have no other home: a security other than the listed stock or a bond, a check box that differs from the latest cover, or a figure not in the Balance Sheet › Equity tabs. Newest first, as filed.
- 2025-03-03: Form 10-K; Item Smaller reporting company; As filed Yes.
- 2024-11-07: Form 10-Q; Item Smaller reporting company; As filed Yes.
- 2024-11-07: Form 10-Q; Item Emerging growth company; As filed Yes.
- 2024-08-08: Form 10-Q; Item Smaller reporting company; As filed Yes.
| Filed | Form | Item | As filed |
|---|---|---|---|
| 2025-03-03 | 10-K | Smaller reporting company | Yes |
| 2024-11-07 | 10-Q | Smaller reporting company | Yes |
| 2024-11-07 | 10-Q | Emerging growth company | Yes |
| 2024-08-08 | 10-Q | Smaller reporting company | Yes |
| 2024-08-08 | 10-Q | Emerging growth company | Yes |
| 2024-05-09 | 10-Q | Smaller reporting company | Yes |
| 2024-05-09 | 10-Q | Emerging growth company | Yes |
| 2024-02-22 | 10-K | Smaller reporting company | Yes |
| 2024-02-22 | 10-K | Emerging growth company | Yes |
| 2024-02-22 | 10-K | Well-known seasoned issuer | No |
| 2023-11-09 | 10-Q | Smaller reporting company | Yes |
| 2023-11-09 | 10-Q | Emerging growth company | Yes |
| 2023-08-10 | 10-Q | Smaller reporting company | Yes |
| 2023-08-10 | 10-Q | Emerging growth company | Yes |
| 2023-05-11 | 10-Q | Smaller reporting company | Yes |
| 2023-05-11 | 10-Q | Emerging growth company | Yes |
| 2023-02-23 | 10-K | Smaller reporting company | Yes |
| 2023-02-23 | 10-K | Emerging growth company | Yes |
| 2023-02-23 | 10-K | Well-known seasoned issuer | No |
| 2022-11-03 | 10-Q | Smaller reporting company | Yes |
| 2022-11-03 | 10-Q | Emerging growth company | Yes |
| 2022-08-04 | 10-Q | Smaller reporting company | Yes |
| 2022-08-04 | 10-Q | Emerging growth company | Yes |
| 2022-05-11 | 10-Q | Smaller reporting company | Yes |
| 2022-05-11 | 10-Q | Emerging growth company | Yes |
| 2022-02-24 | 10-K | Smaller reporting company | Yes |
| 2022-02-24 | 10-K | Emerging growth company | Yes |
| 2022-02-24 | 10-K | Well-known seasoned issuer | No |
| 2021-11-10 | 10-Q | Smaller reporting company | Yes |
| 2021-11-10 | 10-Q | Emerging growth company | Yes |
| 2021-08-09 | 10-Q | Smaller reporting company | Yes |
| 2021-08-09 | 10-Q | Emerging growth company | Yes |
| 2021-05-13 | 10-Q | Stock registered under Section 12(b) | Ordinary Shares, par value $0.0001 per share · EWTX · NASDAQ |
| 2021-05-13 | 10-Q | Smaller reporting company | Yes |
| 2021-05-13 | 10-Q | Emerging growth company | Yes |
| 2021-05-13 | 10-Q | Current in its reporting | No |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Tango Therapeutics, Inc. (TNGX) | United States | $4.154B | -42.53 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 |